European Union · Question · QUESTION_WRITTEN
E-9-2023-000249
The role of MSSG EMA and HMA in the context of drug shortages
Introduced
26 January 2023
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 March 2023
Records
Official question E-9-2023-000249 from European Union at European Parliament. Dated 26 January 2023. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Role of the EMA’s MSSG and the HMA in the context of the medicines shortage
QUESTION_WRITTEN · EN · 1 February 2023
Role of the EMA’s MSSG and the HMA in the context of the medicines shortage
QUESTION_WRITTEN · EN · 1 February 2023
Role of the EMA’s MSSG and the HMA in the context of the medicines shortage
QUESTION_WRITTEN · EN · 1 February 2023
Answer
QUESTION_WRITTEN_ANSWER · 13 March 2023
Rola MSSG EMA i HMA w kontekście braków leków
QUESTION_WRITTEN · PL · 1 February 2023
Rola MSSG EMA i HMA w kontekście braków leków
QUESTION_WRITTEN · PL · 1 February 2023
Rola MSSG EMA i HMA w kontekście braków leków
QUESTION_WRITTEN · PL · 1 February 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.